(ZION) Zions Bancorporation - Overview
Sector: Financial Services | Industry: Banks - Regional | Exchange: NASDAQ (USA) | Market Cap: 8.771m USD | Total Return: 36.6% in 12m
Avg Turnover: 82.9M
EPS Trend: 43.8%
Qual. Beats: 1
Rev. Trend: 80.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Confidence
Zions Bancorporation (ZION) is a major regional banking institution headquartered in Salt Lake City, Utah, operating a collection of distinct local brands across the Western and Southwestern United States. Its business model emphasizes decentralized management, allowing its subsidiary banks-such as Amegy Bank and California Bank & Trust-to maintain local autonomy while leveraging the parent companys centralized technology and capital resources. The company focuses primarily on commercial and small-business banking, offering specialized services including municipal finance, loan syndication, and commercial real estate lending.
As a regional bank, Zions is heavily influenced by interest rate spreads and the economic health of its specific geographic footprint. Unlike global money center banks, regional institutions typically rely more on traditional deposit-taking and middle-market commercial lending rather than investment banking fees. Investors may find ValueRay useful for deeper analysis of these regional banking metrics. Founded in 1873, the firm also maintains a significant presence in retail banking and wealth management, providing residential mortgages and fiduciary services to individual clients.
- Net interest margin sensitivity to Federal Reserve monetary policy shifts
- Commercial real estate loan concentration in Western United States markets
- Non-interest bearing deposit retention levels impact overall funding costs
- Credit quality performance within small and medium-sized business portfolios
- Operational efficiency improvements through technology modernization and branch consolidation
| Net Income: 962.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.22 > 1.0 |
| NWC/Revenue: -1.13k% < 20% (prev -1.34k%; Δ 210.2% < -1%) |
| CFO/TA 0.01 > 3% & CFO 1.29b > Net Income 962.0m |
| Net Debt (-19.0b) to EBITDA (1.35b): -14.14 < 3 |
| Current Ratio: 0.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (147.0m) vs 12m ago -0.24% < -2% |
| Gross Margin: 68.87% > 18% (prev 0.62%; Δ 6.82k% > 0.5%) |
| Asset Turnover: 5.60% > 50% (prev 5.65%; Δ -0.05% > 0%) |
| Interest Coverage Ratio: 0.83 > 6 (EBITDA TTM 1.35b / Interest Expense TTM 1.49b) |
| A: -0.63 (Total Current Assets 21.5b - Total Current Liabilities 77.3b) / Total Assets 88.0b |
| B: 0.09 (Retained Earnings 7.50b / Total Assets 88.0b) |
| C: 0.01 (EBIT TTM 1.23b / Avg Total Assets 88.0b) |
| D: 0.09 (Book Value of Equity 7.23b / Total Liabilities 80.7b) |
| Altman-Z'' = -3.69 = D |
| DSRI: 0.91 (Receivables 340.0m/377.0m, Revenue 4.93b/4.97b) |
| GMI: 0.90 (GM 68.87% / 62.28%) |
| AQI: 0.88 (AQ_t 0.74 / AQ_t-1 0.84) |
| SGI: 0.99 (Revenue 4.93b / 4.97b) |
| TATA: -0.00 (NI 962.0m - CFO 1.29b) / TA 88.0b) |
| Beneish M = -3.27 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 61.79 with a total of 1,220,300 shares traded.
Over the past week, the price has changed by +4.18%,
over one month by +1.05%,
over three months by +5.55% and
over the past year by +36.55%.
Zions Bancorporation has received a consensus analysts rating of 3.17. Therefore, it is recommended to hold ZION.
- StrongBuy: 3
- Buy: 2
- Hold: 15
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 68.8 | 11.3% |
P/E Forward = 9.9206
P/S = 2.5858
P/B = 1.2715
P/EG = 3.4209
Revenue TTM = 4.93b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 1.35b USD
Long Term Debt = 1.47b USD (from longTermDebt, last fiscal year)
Short Term Debt = 382.0m USD (from shortTermDebt, last quarter)
Debt = 2.35b USD (from shortLongTermDebtTotal, last quarter) + Leases 4.00m
Net Debt = -19.0b USD (calculated: Debt 2.35b - CCE 21.4b)
Enterprise Value = 8.77b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.83 (Ebit TTM 1.23b / Interest Expense TTM 1.49b)
EV/FCF = 7.51x (Enterprise Value 8.77b / FCF TTM 1.17b)
FCF Yield = 13.32% (FCF TTM 1.17b / Enterprise Value 8.77b)
FCF Margin = 23.70% (FCF TTM 1.17b / Revenue TTM 4.93b)
Net Margin = 19.52% (Net Income TTM 962.0m / Revenue TTM 4.93b)
Gross Margin = 68.87% ((Revenue TTM 4.93b - Cost of Revenue TTM 1.53b) / Revenue TTM)
Gross Margin QoQ = 72.36% (prev 70.90%)
Tobins Q-Ratio = 0.10 (Enterprise Value 8.77b / Total Assets 88.0b)
Interest Expense / Debt = 63.30% (Interest Expense 1.49b / Debt 2.35b)
Taxrate = 20.75% (61.0m / 294.0m)
NOPAT = 974.8m (EBIT 1.23b * (1 - 20.75%))
Current Ratio = 0.28 (Total Current Assets 21.5b / Total Current Liabilities 77.3b)
Debt / Equity = 0.32 (Debt 2.35b / totalStockholderEquity, last quarter 7.30b)
Debt / EBITDA = -14.14 (Net Debt -19.0b / EBITDA 1.35b)
Debt / FCF = -16.30 (Net Debt -19.0b / FCF TTM 1.17b)
Total Stockholder Equity = 6.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 962.0m / Total Assets 88.0b)
RoE = 13.77% (Net Income TTM 962.0m / Total Stockholder Equity 6.98b)
RoCE = 14.55% (EBIT 1.23b / Capital Employed (Equity 6.98b + L.T.Debt 1.47b))
RoIC = 9.11% (NOPAT 974.8m / Invested Capital 10.7b)
WACC = 8.01% (E(8.77b)/V(11.1b) * Re(10.15%) + (debt cost/tax rate unavailable))
Discount Rate = 10.15% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -53.94 | Cagr: -0.18%
[DCF] Terminal Value 77.97% ; FCFF base≈1.09b ; Y1≈1.25b ; Y5≈1.84b
[DCF] Fair Price = 317.5 (EV 27.7b - Net Debt -19.0b = Equity 46.7b / Shares 147.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 43.76 | EPS CAGR: 4.74% | SUE: 1.10 | # QB: 1
Revenue Correlation: 80.69 | Revenue CAGR: 7.86% | SUE: 0.54 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.61 | Chg30d=+4.02% | Revisions=+24% | Analysts=19
EPS next Quarter (2026-09-30): EPS=1.65 | Chg30d=+1.22% | Revisions=+45% | Analysts=19
EPS current Year (2026-12-31): EPS=6.50 | Chg30d=+4.23% | Revisions=+84% | GrowthEPS=+8.1% | GrowthRev=+2.8%
EPS next Year (2027-12-31): EPS=6.75 | Chg30d=+2.34% | Revisions=+67% | GrowthEPS=+3.8% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: +84%